Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. to broaden the access to its core technology that transforms smartphones into IVD devices.
On Wednesday, the company announced that the publicly-listed Japanese pharma company became its latest partner and shareholder who will help expand its business globally and promote its...
